RE: Heathrow31 Aug 2020 13:14
Taken from recent Investor Presentation
Q1: Please explain your relationship with Mologic. Many investors believe your future sales are too closely linked to their product.
Contract manufacturing arrangement for four Mologic tests:
– Mologic COVID-19 lab-based ELISA antibody test
– Mologic COVID-19 lab-based ELISA antigen test
– Mologic lateral flow antigen test
– Mologic lateral flow antibody test
The first is CE marked and we’ve shipped our first orders, with evaluations being undertaken in 15 countries. The others are in the process of technical transfer and will then gain CE marking – looking at being ready for commercial sales in Sept (Mologic lateral flow antibody test), October / November (Mologic COVID-19 lab-based ELISA antigen test) and a further two months later (Mologic lateral flow antigen test). So COVID-19 sales are very much linked with these Mologic products but we also have a major opportunity in the UK with the UK RTC.